Researchers at the University of Cincinnati are working to extend the lives of those with head and neck cancer through a new combination therapy. As the sixth most common cancer worldwide with high return rates, it is truly life-altering. The study combined radiation therapy with telaglenastat to stop a key enzyme in a cell pathway that alters in cancer cells and causes cells to grow rapidly and resist treatment. Using animal models, the drug reduced the growth of the cancer cells up to 90% and increased the efficacy of radiation in animals by 40%. | https://medicalxpress.com/news/2021-01-drug-therapy-effective-neck-cancer.html.